Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma

NCT06749730 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

63

Enrollment

OTHER_GOV

Sponsor class

Conditions

Unresectable Biliary Tract Carcinoma

Interventions

DRUG: Adebrelimab
DRUG: Apatinib
DRUG: gemcitabine and cisplatin

Sponsor

Henan Cancer Hospital